LL didn't say that. Al Musella did. She specifically said the DCVax is the trade name. It's the process developed by UCLA.
Al Musella:
Okay. You can stop sharing. I’m sorry. You talked about autologous dendritic cells for the new trials. Is that the same thing as DCVax-L? Dr. Linda Liau:
Um, well, you know, DCVax-L is a trade name that is actually licensed by Northwest Biotherapeutics,
Al Musella:
But it’s the same process, basically.
Dr. Linda Liau:
Yes. So, yes, we developed the process. At UCLA.
Market Data 
Markets 
AI
